This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Gallardo D, De la Camara R, Torres A, Brunet S, Jimenez A, Vallejo JC et al. Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia 2004; 18: 1031–1034.
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML10 trial. Blood 1998; 92: 2322–2333.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075–4083.
Burnett AK . Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? – an adult treater's view. Br J Haematol 2002; 118: 357–364.
Giles FJ, Keating A, Goldstone AH, Avivi I, Willman CL, Kantarjian HM . Acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2002, 73–110.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kennedy, G., Butler, J., Western, R. et al. Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia 19, 317–318 (2005). https://doi.org/10.1038/sj.leu.2403549
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403549